Better treatment of inflammatory diseases through comprehensive systems biology (OMICS) - Tue Bjerg Bennike, dr.med., PhD, MS
As Group Leader for Clinical Proteomics Research, Aalborg University, my personal aim is to advance the treatment of inflammatory diseases, focusing on the inflammatory bowel diseases (IBD). The inflammatory diseases remain poorly understood, limiting the development of treatments and diagnostics. Through my research, I aim to bridge this knowledge-gap and understand the underlying biology, to ultimately translate this to meaningful advances in treatment options and patient care..
My research focus is the innate immune system. I perform comprehensive systems biology (OMICS) characterization of clinical samples from patients and cellular assays, using proteomics, combined with advanced microscopy, bioinformatics, and machine learning/AI.
Proteomics is the characterization of the protein composition, the proteome, of a biological sample. While several techniques exists and new continue to emerge, mass spectrometry-driven proteomics remains a widely used core technology in proteomics for large-scale characterization of the proteome. For an review of the commonly applied bottom-up mass spectrometry-driven proteomics workflow, designed to be accessible even to those new to the field please click here.
For a list of my publications please click here.
Email: [email protected]
Website: proteomics.dk
Aalborg University Profile
LinkedIn